Yes, there was the small matter of a global pandemic, but this may also have been the year obesity levels ceased their inexorable rise and began to descend. Around the world, obesity rates have ...

NHS leaders are considering a phased rollout of the obesity injection tirzepatide (Mounjaro, Eli Lilly) because of potentially high demand. The National Institute for Health and Care Excellence (NICE) ...

If you’re dedicated to dipping, Smith tells The Post that full-fat versions of nut butters are better for the body than diet or reduced-fat options. Sourdough bread, the carbohydrate star of ...

Find anything you save across the site in your account Find anything you save across the site in your account All products are independently selected by our editors. If you buy something, we may ...

The proposed maximum duration of the roll-out is unprecedented, and new ways of delivering obesity medicines, including digital services, will need to be established to allow a more rapid expansion.

Here's everything you need to know about this year's edition of Fat Bear Week. It's a celebration of Alaska's rotund brown bears ahead of their hibernation season. The annual event has gained ...

They found evidence that obesity tends to spur lighter medical and psychological harms when those who struggle with the disorder feel less conspicuous. Individuals struggling with obesity face a ...

Research published in 2023 was based on 58 studies that included more than 1.1 million people ages 65 and older. Its focus was the "obesity paradox," in which extra weight may have a protective effect ...

Kailera Therapeutics has launched into the increasingly crowded obesity space with a portfolio of assets acquired from China and $400 million in series A funds. The Massachusetts- and California ...

Visceral fat is one of the most harmful types of fat, as it surrounds your internal organs and poses serious health risks, including an increased likelihood of developing cardiovascular diseases, type ...

Rivus Pharmaceuticals has unveiled the data behind its phase 2 obesity win in heart failure patients, showing that the candidate can indeed help patients reduce weight while they retain muscle.